Investor Relations
About Vivani
Vivani Medical is an emerging biopharmaceutical company developing a pipeline of miniature, ultra long-term drug implants with its proprietary NanoPortal™ platform technology for obesity/weight management and other chronic diseases.
Vivani’s lead drug implant candidates are designed to improve medication adherence and deliver smooth consistent therapeutic levels of GLP-1 – the same class of active pharmaceutical ingredients in Ozempic®, Trulicity® and Wegovy® – for 6 months, 12 months, or longer with a single administration. NPM-139 and NPM-133, are miniature, six-month, GLP-1 (semaglutide) implants under development for obesity/chronic weight management and the treatment of type 2 diabetes, respectively.
NanoPortal™ has broad potential application across a range of molecule types including peptide therapeutics.